Alkem Laboratories Ltd.

BSE: 539523 | NSE: ALKEM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE540L01014 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Alkem Laborato Alkem Laboratories Ltd. | BSE 5524.00 -39.80 (-0.72%) | NSE 5535.00 -31.00 (-0.56%) | Trade | Add

BSE Live

Dec 26, 16:01

5524.00 -39.80 (-0.72%)

Volume

AVERAGE VOLUME

5-Day

406

10-Day

480

30-Day

5,809

104

Prev. Close

5563.80
Open Price

5563.80

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Dec 26, 15:56

5535.00 -31.00 (-0.56%)

Volume

AVERAGE VOLUME

5-Day

47,647

10-Day

48,938

30-Day

125,733

40,414

Prev. Close

5566.00
Open Price

5539.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
5535.00 (39)

Financials

Print/Copy to Excel : Go

Balance Sheet of Alkem Laboratories (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	23.91	23.91	23.91	23.91	23.91
Total Share Capital	23.91	23.91	23.91	23.91	23.91
Reserves and Surplus	6,135.40	5,415.43	4,839.86	4,443.73	3,668.05
Total Reserves and Surplus	6,135.40	5,415.43	4,839.86	4,443.73	3,668.05
Total Shareholders Funds	6,160.67	5,439.34	4,863.77	4,467.64	3,691.96
Minority Interest	148.30	132.61	121.55	115.23	95.02
NON-CURRENT LIABILITIES
Long Term Borrowings	73.91	231.30	130.73	181.56	123.46
Deferred Tax Liabilities [Net]	0.00	0.30	1.67	0.47	1.01
Other Long Term Liabilities	95.10	13.39	14.33	11.29	2.65
Long Term Provisions	222.98	173.72	150.27	102.17	82.96
Total Non-Current Liabilities	391.99	418.71	297.00	295.49	210.08
CURRENT LIABILITIES
Short Term Borrowings	1,503.51	671.27	761.27	472.37	464.17
Trade Payables	954.05	962.25	960.71	741.37	580.48
Other Current Liabilities	593.64	430.19	537.39	351.51	388.26
Short Term Provisions	193.38	153.82	123.94	124.44	104.69
Total Current Liabilities	3,244.58	2,217.53	2,383.31	1,689.69	1,537.60
Total Capital And Liabilities	9,945.54	8,208.19	7,665.63	6,568.05	5,534.66
ASSETS
NON-CURRENT ASSETS
Tangible Assets	2,306.29	2,105.62	1,873.30	1,394.45	1,031.03
Intangible Assets	203.27	44.26	64.90	57.75	65.45
Capital Work-In-Progress	362.97	492.96	380.97	299.26	172.42
Fixed Assets	2,872.53	2,642.84	2,319.17	1,751.46	1,268.90
Non-Current Investments	91.50	95.74	196.47	259.44	234.39
Deferred Tax Assets [Net]	932.57	707.63	655.61	696.27	516.23
Long Term Loans And Advances	10.61	13.63	22.22	21.50	8.72
Other Non-Current Assets	134.23	151.66	211.57	577.40	384.66
Total Non-Current Assets	4,439.89	3,992.06	3,750.44	3,650.91	2,765.96
CURRENT ASSETS
Current Investments	169.89	227.88	247.80	293.56	274.18
Inventories	1,818.82	1,499.87	1,442.19	1,206.00	909.37
Trade Receivables	1,649.36	1,248.41	1,080.50	713.64	567.51
Cash And Cash Equivalents	1,092.21	661.60	576.78	399.26	780.90
Short Term Loans And Advances	27.97	30.80	37.92	27.95	9.85
OtherCurrentAssets	747.40	547.57	530.00	276.73	226.89
Total Current Assets	5,505.65	4,216.13	3,915.19	2,917.14	2,768.70
Total Assets	9,945.54	8,208.19	7,665.63	6,568.05	5,534.66
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	357.59	436.60	464.73	488.58	0.00
BONUS DETAILS
Bonus Equity Share Capital	11.96	11.96	11.96	11.96	11.96
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	0.00	153.04	228.22	204.34
Non-Current Investments Unquoted Book Value	36.74	40.76	43.44	31.23	30.05
CURRENT INVESTMENTS
Current Investments Quoted Market Value	0.00	0.00	22.40	17.15	1.27
Current Investments Unquoted Book Value	152.50	187.12	225.40	276.42	274.18